ISTH 2020 Congress
Hemophilia and Rare Bleeding Disorders » Hemophilia - Clinical
Theme Navigation
- ISTH 2020 Congress
- Hemophilia and Rare Bleeding Disorders
- Hemophilia - Clinical
- Hemophilia and Rare Bleeding Disorders
Abstract Number: PB0972
“Best of Both Worlds”: Combination Treatment of Desmopressin and FVIII Concentrates in Hemophilia Patients Optimizes Therapy and Reduces Costs
Abstract Number: PB1058
Case report: Inhibitor Improvement with Low Dose Immune Tolerance Induction (ITI) with rFVIIIFc and Emicizumab after Failed First Line Therapy with High Dose ITI
Abstract Number: PB1041
3D Gait Analysis, Hemophilia Joint Health Score, Leg Muscle Laterality, and Biomarkers of Joint Damage: A Cross-sectional Comparative Assessment of Hemophilic Arthropathy
Abstract Number: PB0905
A Canadian, Multi-Center, Retrospective, Non-Interventional Study of Clinical Outcomes from Early Use of N9-GP Compared with Previous Treatment in Patients with Hemophilia B in a Real-World Setting
Abstract Number: PB1075
A Descriptive Study of Physical Activity and Fitness Level Profiles of Nigerians with Haemophila
Abstract Number: PB0896
A Randomized Controlled Trial: Pharmacokinetic-Guided Dosing of Factor VIII Concentrate Versus Standard Replacement Therapy in Perioperative Hemophilia A Patients (OPTI-CLOT Trial)
Abstract Number: PB0875
A Real-World Qualitative Analysis of the Burden of Hemophilia B and Patient Experiences with Prophylactic Nonacog Beta Pegol
Abstract Number: PB1053
A Simplified Health Education Program Improves Knowledge and Practices of Home Treatment in Hemophilia A Adolescents in a Developing Country
Abstract Number: PB0953
A Single Center Data on Extended Half-Life Recombinant Factor VIII (FVIII:Fc) in Patients with Hemophilia A
Abstract Number: PB1062
A Snapshot of a Prospective, Non-interventional Study to Evaluate Routine Practice Prophylactic Treatment Schedules – NIS-Previq
Abstract Number: PB0954
Abdominal Catastrophe in Hemophilic Patients: Towards Wise Decision Making
Abstract Number: OC 09.3
An Insight into Clinical Outcomes in Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study
Abstract Number: PB1055
ASCVD Risk Score among Haemophilia Patients: Time to Formally Evaluate Cardiovascular Risk in People with Haemophilia
Abstract Number: PB0897
Assessing the Bleeding Phenotype in Non-Severe hemophilia by use of the ISTH Bleeding Assessment Tool (BAT)